Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Janis K. Lazdins-Helds"'
Publikováno v:
Parasites & Vectors, Vol 8, Iss 1, Pp 1-15 (2015)
Abstract Background Elimination of onchocerciasis in Africa is now regarded as an achievable goal in many areas. This makes monitoring changes in infection prevalence a key component of control programmes. Monitoring is currently based on determining
Externí odkaz:
https://doaj.org/article/36ef5bbc5e4f48f59498fc3df193c5a7
Autor:
John M. Kelly, Phillip Scott, Rick L. Tarleton, Jonathan M. Spector, Catherine L. Jones, José Mengel, Jeremy C. Mottram, Claudio Gimpelewicz, Michael P. Barrett, Pascal Mäser, Christopher J. Faraday, David L. Sacks, Gerald F. Späth, Srinivasa P. S. Rao, Thierry T. Diagana, Glenn Dranoff, Asrat Hailu, Janis K. Lazdins-Helds, Charles E. Mowbray
Publikováno v:
ACS Infectious Diseases
ACS Infectious Diseases, American Chemical Society, 2018, ⟨10.1021/acsinfecdis.8b00298⟩
ACS Infectious Diseases, 2018, ⟨10.1021/acsinfecdis.8b00298⟩
ACS Infectious Diseases, American Chemical Society, 2018, ⟨10.1021/acsinfecdis.8b00298⟩
ACS Infectious Diseases, 2018, ⟨10.1021/acsinfecdis.8b00298⟩
International audience; Kinetoplastid parasites have caused human disease for millennia. Significant achievements have been made toward developing new treatments for leishmaniasis (particularly on the Indian subcontinent) and for human African trypan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2eba2309dadb2c9c67d6eec1eb23ddf
https://eprints.whiterose.ac.uk/139513/1/Mottram_Rao_et_al_Kinetoplastid_Viewpoint_ACSID_proof.pdf
https://eprints.whiterose.ac.uk/139513/1/Mottram_Rao_et_al_Kinetoplastid_Viewpoint_ACSID_proof.pdf
Autor:
Charles D. Mackenzie, Timothy G. Geary, Piero Olliaro, Katherine Woo, James S. McCarthy, Donald A. P. Bundy, John Horton, Janis K. Lazdins-Helds, Dirk Engels, Nilanthi de Silva, Roger K. Prichard
Publikováno v:
International Journal for Parasitology. 40:1-13
Helminth infections are an important constraint on the health and development of poor children and adults. Anthelmintic treatment programmes provide a safe and effective response, and increasing numbers of people are benefitting from these public hea
Publikováno v:
Parasites & Vectors
Elimination of onchocerciasis in Africa is now regarded as an achievable goal in many areas. This makes monitoring changes in infection prevalence a key component of control programmes. Monitoring is currently based on determining the presence of O.
Autor:
Kwablah Awadzi, Daniel A. Boakye, Geoffrey Edwards, K. Ahmed, B. T. Quartey, Boakye A. Boatin, Janis K. Lazdins-Helds, Simon K. Attah, E. T. Addy, N. O. Opoku
Publikováno v:
Annals of Tropical Medicine & Parasitology. 98:359-370
The pathogenesis of the sub-optimal response of Onchocerca volvulus to ivermectin was investigated in a 30-month follow-up of 28 individuals who, in a previous study, had been found to show a sub-optimal (N = 15) or adequate response (N = 13) to mult
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 6, p e2953 (2014)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Control of onchocerciasis as a public health problem in Africa relies on annual mass ivermectin distribution. New tools are needed to achieve elimination of infection. This study determined in a small number of Onchocerca volvulus infected
Autor:
Simon K. Attah, E. T. Addy, Mike Y. Osei-Atweneboana, A. E. Ardrey, E. W. Soumbey-Alley, Geoffrey Edwards, Daniel A. Boakye, Kwablah Awadzi, K. Ahmed, Janis K. Lazdins-Helds, Boakye A. Boatin, B. T. Quartey, N. O. Opoku
Publikováno v:
Annals of tropical medicine and parasitology. 98(3)
If ivermectin-based programmes for the control of human onchocerciasis are to be successful, the drug must remain effective for as long as necessary. In an open, case-control study, an attempt was made to determine if the persistent, significant, Onc
Publikováno v:
Acta Tropica. 119:67-68
Publikováno v:
International Journal for Parasitology. (7):395-404
In recent years, control of neglected tropical diseases has been increasingly gaining momentum and interventions against schistosomiasis are being progressively scaled-up through expansion of donated praziquantel and preventive chemotherapy campaigns